Moderna’s Flu Vaccine Uncertainty Highlights FDA Leadership Turmoil
Moderna, the biotechnology firm known for its COVID-19 vaccine, is facing significant…
Biotech IPO Market Shows Signs of Reopening in 2026
The biotech industry appears to be on the cusp of a resurgence,…
HBAR Shows Signs of Potential Bullish Breakout Despite Bitcoin’s Influence
The price of Hedera (HBAR) has experienced a downturn in recent sessions,…
Bitcoin Falls Below $66,000 Amid US Economic Concerns and Government Shutdown Fears
Bitcoin (BTC) has resumed its downward trend, trading at approximately $65,645 after…
EUR/USD Struggles Amidst Negative Momentum but Technical Indicators Remain Constructive
The EUR/USD currency pair continues to struggle, remaining in negative territory for…
European Shares Open Lower Amid AI Jitters and Wall Street Sell-Off
European stocks experienced a downturn on Friday as concerns surrounding artificial intelligence…
$3 Billion Bitcoin and Ethereum Options Expiry Puts Market Sentiment to the Test
In a noteworthy event today, nearly $3 billion in Bitcoin and Ethereum…
Solana Price Declines Below $85 Amid Market Correction
Solana's recent trading performance has shown signs of a notable correction following…
Moderna Caught Off Guard by FDA’s Refusal to Review Influenza Vaccine Application
In a surprising turn of events, officials from the Food and Drug…
Alphabet Positioned for Long-Term Success Amid Market Volatility
Alphabet Inc. continues to present itself as a resilient player in the…